A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PCP
Long Form : procollagen C-proteinase
No. Year Title Co-occurring Abbreviation
2012 Design and synthesis of procollagen C-proteinase inhibitors. ---
2009 Different patterns of human serum procollagen C-proteinase enhancer1 (PCPE1). BMP-1, PCPE1, sPCPE1
2008 Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge. ADAMs, ADAMTSs, MMPs
2008 Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents. ---
2007 Potent and selective nonpeptidic inhibitors of procollagen C-proteinase. TED
2007 The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains. BMP-1
2006 Inhibition of procollagen C-proteinase reduces scar hypertrophy in a rabbit model of cutaneous scarring. ---
2006 Mammalian tolloid-like 1 binds procollagen C-proteinase enhancer protein 1 and differs from bone morphogenetic protein 1 in the functional roles of homologous protein domains. BMP-1, mTLL-1, PCOLCE1
2006 The interaction of recombinant subdomains of the procollagen C-proteinase with procollagen I provides a quantitative explanation for functional differences between the two splice variants, mammalian tolloid and bone morphogenetic protein 1. ---
10  2005 Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase enhancer-1 (PCPE-1). BMP-1, mTLL-2, PCPE-1
11  2003 Bone morphogenetic protein-1 (BMP-1). Identification of the minimal domain structure for procollagen C-proteinase activity. BMP-1, EGF, mTld
12  2003 Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for co-regulation with type I collagen. ---
13  2003 Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases. BMP-1, ECM, mTLD, mTLL-1
14  2002 Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase. Part 2: Solid-phase optimization of side chains. ---
15  2001 Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues. ---
16  2001 Identification of amino acid residues in bone morphogenetic protein-1 important for procollagen C-proteinase activity. BMP
17  2000 Design and synthesis of acidic dipeptide hydroxamate inhibitors of procollagen C-proteinase. ---
18  2000 Solid-phase synthesis of di- and tripeptidic hydroxamic acids as inhibitors of procollagen C-proteinase. ---
19  1997 The CUB domains of procollagen C-proteinase enhancer control collagen assembly solely by their effect on procollagen C-proteinase/bone morphogenetic protein-1. BMP-1, PCPE
20  1997 Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. BMP-1, mTld, PCPE, TGF-beta1
21  1996 Bone morphogenetic protein-1: the type I procollagen C-proteinase. BMPs, TGF-beta, Tld